Ro started in 2017 as Roman, a men’s telehealth brand focused almost entirely on erectile dysfunction. Nearly a decade later it has rebranded, raised more than $1 billion in venture capital, and expanded into weight loss, hair loss, fertility, dermatology, sexual health, and primary-care-adjacent services. This ro review walks through what the platform actually charges as of 2026, which conditions it treats well, where the model falls short, and how it compares to the rest of the direct-to-consumer telehealth landscape. If you’re considering Ro for a GLP-1 prescription, hair loss, or general care, the answer depends heavily on which condition you’re treating and whether you have insurance.
Medical disclaimer: This article is general information, not medical advice, and prices are 2026 estimates that change often. Any prescription through Ro or any telehealth platform still requires evaluation by a licensed clinician, and you should confirm current costs and clinical appropriateness directly with the provider and your own doctor.
What Ro is and how the platform works
Ro is a direct-to-consumer telehealth company that operates a connected mail-order pharmacy and a network of contracted physicians, nurse practitioners, and physician assistants. You pick a treatment area on Ro’s website, fill out an intake questionnaire, and a licensed clinician reviews your case, usually within 24-48 hours. If the clinician determines treatment is appropriate, the prescription ships from Ro’s affiliated pharmacy directly to your door, typically within a few business days.
Historically much of Ro’s model was asynchronous, meaning many patients never spoke with a clinician on video. That has shifted: Ro now offers synchronous video and phone visits for certain conditions, especially weight loss, while routine refills and renewals still often run through secure messaging. Prescribing decisions are made by the clinician, not the questionnaire, and controlled or higher-risk medications require more scrutiny. For a wider view of how this kind of platform fits the broader online care market, see our guide to telehealth.
What Ro costs in 2026
Ro pricing varies significantly by condition, and the figures below are typical 2026 ranges rather than fixed quotes — always confirm on the site before subscribing. The intake visit itself typically runs about $15-25 for most conditions, though the weight-loss evaluation is priced higher. Erectile dysfunction medications like generic sildenafil typically start around a couple of dollars per dose, with generic tadalafil often running a few dollars per dose depending on quantity and strength.
Hair-loss treatment with oral finasteride typically lands in the low-to-mid $20s per month, and topical minoxidil adds roughly $15-20; bundled hair packages that combine medications generally run in the $40s per month. Ro Skin’s tretinoin-based formulations are typically priced in the $30-50 range per month. For the weight-loss program, expect a monthly membership commonly cited in the $99-145 range as of 2026, charged separately from the medication itself. Branded Wegovy and Zepbound remain expensive without insurance — often clearing $1,000 per month at list price, though manufacturer self-pay vial programs have brought some options well below that. All of this sits within our broader breakdown of US healthcare costs.
What Ro treats well
Ro is strongest in the areas where it built its early reputation: erectile dysfunction, premature ejaculation, hair loss, dermatology, and sexual-health prevention. The intake forms are tight, the formulary is well-curated, and pricing on generics is competitive. Hair loss in particular is a category where Ro’s bundled pricing usually beats both Hims and a brick-and-mortar dermatologist, especially for patients who don’t want to add a separate dermatology visit just to get a finasteride prescription.
The weight-loss program has been Ro’s biggest growth driver since the GLP-1 boom. The program includes a clinician visit, review of relevant labs, ongoing check-ins, and access to GLP-1 medications where clinically appropriate. Patients with eligible insurance can sometimes use it to access branded Wegovy or Zepbound through Ro’s pharmacy partners, though approval and coverage vary widely. The FDA’s guidance on GLP-1 drugs is worth reading before you sign up, especially given how much the compounding landscape shifted in 2025.
How the 2025 compounding shakeup changed Ro’s GLP-1 program
This is the single biggest thing that has changed since earlier Ro reviews. Through 2023 and 2024, many telehealth companies — Ro among them — offered compounded semaglutide and tirzepatide, which were legal to compound in large volumes only because the branded drugs were on the FDA’s shortage list. The FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in early 2025, and the agency set wind-down deadlines that, by the second half of 2025, ended most mass-market compounding of these molecules.
As a result, in 2026 Ro’s GLP-1 pathway leans much more on FDA-approved branded medications — typically branded Wegovy and Zepbound — often paired with manufacturer self-pay options such as Eli Lilly’s LillyDirect and Novo Nordisk’s NovoCare pharmacy, which have offered single-dose vials at reduced cash prices (frequently cited in the several-hundred-dollars-per-month range as of 2026, versus four-figure list prices). The FDA has repeatedly cautioned against sourcing compounded GLP-1s from platforms offering suspiciously cheap pricing without proper oversight, and has logged hundreds of adverse-event reports tied to compounded versions. If a telehealth ad promises a bargain compounded GLP-1 in 2026, treat that as a reason for extra scrutiny, not a deal.
Where Ro falls short
Ro is not a substitute for primary care, despite the push into broader categories. The platform doesn’t manage chronic conditions like type 2 diabetes, hypertension, or cardiovascular disease the way a true primary care doctor would, and there’s no continuity-of-care guarantee — you may not get the same clinician on follow-up. For patients with multiple conditions or complex medication histories, that fragmentation matters.
Insurance integration is the second weak point. Ro doesn’t bill insurance for visits, and the medication side is a mixed bag: some prescriptions can be sent to a local pharmacy where they may be covered, but the membership and program fees themselves are out of pocket. Patients expecting an in-network telehealth experience will be frustrated. Customer-service complaints, particularly around cancellations and unexpected charges on auto-renewing subscriptions, also show up consistently in Better Business Bureau filings and in user forums, so read the cancellation terms carefully before you enroll.
Ro for weight loss specifically
Ro’s weight-loss program is the most common reason new patients sign up in 2026, so it deserves its own breakdown. The program charges a monthly membership (commonly cited in the $99-145 range) and includes a clinical evaluation, ongoing care, and access to GLP-1 medications where appropriate. Because the compounded options that were widely available in 2023-2024 have largely been withdrawn, the realistic 2026 path is a branded medication — with cost driven primarily by the manufacturer’s price, your insurance, and any manufacturer self-pay program you qualify for. Ro’s own membership fee is separate from the drug cost, so budget for both.
If you’re weighing the GLP-1 path, our comparison of Ro weight loss vs Hims weight loss goes deeper into the side-by-side, and our best telehealth for weight loss guide covers the full field including coaching-heavy programs. Calibrate vs Found is also worth reading if you want a coaching-forward program rather than Ro’s lighter-touch model. Whichever you choose, GLP-1 therapy should be started and monitored by a clinician who reviews your history — never dosed from an online schedule alone.
How Ro compares to Hims, Sesame, and PlushCare
Against Hims, Ro tends to win on hair-loss bundling and compete closely on weight loss. Both companies have leaned into branded GLP-1 access and manufacturer self-pay partnerships since the compounding wind-down, so the deciding factors in 2026 are often membership price, prescriber discretion, and customer service rather than headline compounded pricing. Our deeper Ro vs Hims comparison breaks down the numbers head-to-head.
Compared to Sesame Care, Ro is an entirely different model — Sesame is a marketplace where you book individual cash-pay video visits with independent clinicians, while Ro is a vertically integrated brand with its own pharmacy. Sesame is usually cheaper for one-off needs like a UTI prescription or a sick visit; Ro is better for ongoing, condition-specific subscriptions. PlushCare sits in the middle: it accepts most major insurance, has a true primary-care model with continuity, and prescribes GLP-1s but doesn’t run its own pharmacy.
Privacy, data, and what Ro does with your information
Ro is a HIPAA-covered entity, which means your medical information is protected under federal law. Its privacy policy permits Ro to use de-identified data for product development and research, and Ro participates in certain data-sharing arrangements with manufacturers for some branded products. The Federal Trade Commission’s enforcement actions against other telehealth companies, including the BetterHelp settlement, raised the bar for what telehealth companies can do with marketing pixels and third-party trackers, and platforms across the sector have tightened their practices in response. Read the current privacy policy directly before signing up if data sharing is a concern.
Frequently Asked Questions
Does Ro accept insurance?
Ro does not bill insurance for the visit fee or for its membership programs. Some prescriptions written by Ro clinicians can be sent to a retail pharmacy where insurance may apply, and Ro’s GLP-1 program offers help navigating coverage for branded Wegovy and Zepbound. Plan to pay out of pocket for the membership and most program fees.
Is Ro the same as Roman?
Yes. Ro is the parent brand; Roman was the original men’s-health brand and now operates as Ro’s men’s vertical. Hims is a separate, competing company.
Does Ro still offer compounded semaglutide?
Not the way it did in 2023-2024. After the FDA declared the semaglutide and tirzepatide shortages resolved and set 2025 wind-down deadlines, large-scale compounding of these molecules largely ended. In 2026 Ro’s GLP-1 pathway centers on FDA-approved branded medications, sometimes paired with manufacturer self-pay programs. Be skeptical of any platform still advertising cheap compounded GLP-1s.
How long does Ro take to ship medications?
Most prescriptions ship within a few business days of clinician approval and arrive shortly after. Branded specialty medications can take longer depending on pharmacy stock and prior-authorization steps.
Can I cancel a Ro subscription anytime?
Yes, but auto-renewals are a common complaint. Cancel through the account portal or by contacting customer service before your next billing date, and keep confirmation. Some patients report needing to contact support directly rather than relying on the website alone.
Does Ro prescribe controlled substances?
Ro does not prescribe Schedule II controlled substances like Adderall or oxycodone. A limited set of lower-schedule medications may be available in specific categories where DEA telemedicine flexibilities apply. Read the latest DEA telemedicine rules for the current state of online controlled-substance prescribing.
TL;DR: Is Ro worth it in 2026?
- Best for: hair loss, ED, premature ejaculation, and dermatology, where bundled subscriptions and competitive generic pricing beat a brick-and-mortar visit.
- Weight loss: the program works, but 2026 pricing hinges on branded GLP-1 costs and manufacturer self-pay programs — not the cheap compounded options that largely disappeared in 2025.
- Costs (typical 2026): intake visits about $15-25; weight-loss membership roughly $99-145/month; medications billed separately. Confirm current prices on the site.
- Not for: primary care or complex chronic disease — consider PlushCare, a traditional doctor, or a direct primary care practice. For one-off prescriptions, Sesame Care is usually cheaper.
- Remember: every prescription requires a licensed clinician’s evaluation, and no online questionnaire replaces that.
The bottom line on Ro
Ro is a strong choice for hair loss, ED, and dermatology, where the bundled subscription model and competitive generic pricing genuinely save money over a brick-and-mortar dermatology visit. For weight loss, the program is legitimate, but in 2026 it is defined by branded GLP-1 access and manufacturer self-pay economics rather than the bargain compounded pricing of a few years ago, so it’s worth checking Ro, Hims, and a couple of alternatives before subscribing. As primary care, Ro is too thin — patients with chronic conditions or complex needs will get more value from PlushCare, a traditional doctor, or a direct primary care practice. For one-off prescriptions, Sesame Care is usually cheaper.
Sources
- U.S. Food & Drug Administration — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- Federal Trade Commission — BetterHelp enforcement order on consumer health data
- Better Business Bureau — company profiles and complaint records
- Ro — official platform, current pricing and services
- Manufacturer self-pay programs: Eli Lilly LillyDirect (Zepbound) and Novo Nordisk NovoCare (Wegovy) — current cash-pay vial pricing.